216 related articles for article (PubMed ID: 6363649)
21. [Phase I study of interferon-beta (MR-21) in patients with malignant tumors. The Cooperative Study Group of (MR-21) in Tumor].
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):919-27. PubMed ID: 3694000
[No Abstract] [Full Text] [Related]
22. Studies with interferon-alpha in human tumors.
Einhorn S; Strander H
Med Oncol Tumor Pharmacother; 1984; 1(2):97-9. PubMed ID: 6400035
[TBL] [Abstract][Full Text] [Related]
23. [Clinical efficacy of interferon-beta (MR-21) in hematological malignancies].
Imamura Y
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):934-41. PubMed ID: 3694002
[No Abstract] [Full Text] [Related]
24. Interferon: a new name in cancer treatment.
Lancaster J
Nurs RSA; 1987 Feb; 2(2):28-9. PubMed ID: 2438555
[No Abstract] [Full Text] [Related]
25. [Assessment of the formation of antibodies to interferon in patients with juvenile respiratory papillomatosis on interferon therapy].
Kol'tsov VD; Chireshkin DG; Onufrieva EK; Nurmukhametov RKh; Malinovskaia VV; Ershov FI
Vestn Otorinolaringol; 1996; (4):25-7. PubMed ID: 8966873
[TBL] [Abstract][Full Text] [Related]
26. [Alpha-interferon treatment of juvenile laryngeal papillomatosis in adults].
Schuurman AM; van den Broek P
Ned Tijdschr Geneeskd; 1985 Dec; 129(52):2507-9. PubMed ID: 4088374
[No Abstract] [Full Text] [Related]
27. Treatment of recurrent respiratory papillomatosis with interferon.
Sessions RB; Dichtel WJ; Goepfert H
Ear Nose Throat J; 1984 Oct; 63(10):488-93. PubMed ID: 6489206
[No Abstract] [Full Text] [Related]
28. [Clinical experience with alpha and beta interferon in childhood cancer].
Ise T; Ohira M; Takayama J; Hanada M; Muchi H; Fukuma H; Beppu Y; Nomura K
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1855-62. PubMed ID: 6591860
[TBL] [Abstract][Full Text] [Related]
29. Interferon therapy in juvenile laryngeal papillomatosis.
Lundquist PG; Haglund S; Carlsöö B; Strander H; Lundgren E
Otolaryngol Head Neck Surg; 1984 Aug; 92(4):386-91. PubMed ID: 6207477
[TBL] [Abstract][Full Text] [Related]
30. [Effect of alpha-leukocyte interferon on laryngeal papillomatosis in children].
Vacher S; Peytral C; Narcy P
Presse Med; 1985 Jun; 14(24):1317-8. PubMed ID: 3161020
[TBL] [Abstract][Full Text] [Related]
31. [Interferon-alpha].
Furue H; Mugitani H; Hirota F; Suminaga M
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):797-803. PubMed ID: 3291773
[TBL] [Abstract][Full Text] [Related]
32. [Clinical effect of human lymphoblastoid interferon in patients with multiple myeloma].
Yoshida M; Ohta M; Muroi K; Takeda K; Kitagawa S; Tsuboyama A; Sakamoto S; Miura Y; Mutoh Y
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1394-8. PubMed ID: 6742866
[TBL] [Abstract][Full Text] [Related]
33. Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results.
Sarna G; Figlin R; McCarthy S
J Biol Response Mod; 1983; 2(2):187-95. PubMed ID: 6644335
[TBL] [Abstract][Full Text] [Related]
34. Treatment of multiple myeloma with recombinant human leukocyte A interferon.
Ohno R; Kimura K; Amaki I; Imamura Y; Masaoka T; Miyazaki T; Yoshida Y; Miura Y; Maekawa T; Oguro M
Cancer Treat Rep; 1985 Dec; 69(12):1433-5. PubMed ID: 4075317
[TBL] [Abstract][Full Text] [Related]
35. [Current status and problems of cancer treatment with interferon].
Ichikawa H
Gan No Rinsho; 1983 May; 29(6):616-9. PubMed ID: 6876430
[TBL] [Abstract][Full Text] [Related]
36. Interferon joins attack on severe laryngeal papilloma.
White EC
JAMA; 1983 Oct; 250(14):1815. PubMed ID: 6620472
[No Abstract] [Full Text] [Related]
37. Recombinant interferon-alpha-2C in laryngeal papillomatosis: preliminary results of a prospective multicentre trial.
Zenner HP; Kley W; Clarós P; Clarós A; Labas Z; Löbe LP; Pavelka R; Plath P; Ribari O; Niethammer D
Oncology; 1985; 42 Suppl 1():15-8. PubMed ID: 3909032
[TBL] [Abstract][Full Text] [Related]
38. Phase I study of weekly high-dose human lymphoblastoid interferon.
Connors JM; Silver HK
Cancer Treat Rep; 1984 Sep; 68(9):1093-6. PubMed ID: 6478449
[TBL] [Abstract][Full Text] [Related]
39. [Recent findings in the field of oncological therapy with interferon].
Pugliese A; Vitale M; Cosseta P
G Batteriol Virol Immunol; 1981; 74(7-12):308-19. PubMed ID: 6182049
[No Abstract] [Full Text] [Related]
40. [Molecular-biological aspects of juvenile respiratory papillomatosis and its combined treatment].
Geraĭn V; Chireshkin DG
Vestn Otorinolaringol; 1996; (4):3-8. PubMed ID: 8966875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
